首页> 外文期刊>Current Microbiology: An International Journal >Bioprospecting of Novel and Bioactive Compounds from Marine Actinomycetes Isolated from South China Sea Sediments
【24h】

Bioprospecting of Novel and Bioactive Compounds from Marine Actinomycetes Isolated from South China Sea Sediments

机译:从南海沉积物中分离的海洋放线菌的新型和生物活性化合物的生物掩模

获取原文
获取原文并翻译 | 示例
           

摘要

Marine actinomycetes are less investigated compared to terrestrial strains as potential sources of natural products. To date, few investigations have been performed on culturable actinomycetes associated with South China Sea sediments. In the present study, twenty-eight actinomycetes were recovered from South China Sea sediments after dereplication by traditional culture-dependent method. The 16S rRNA gene sequences analyses revealed that these strains related to five families and seven genera. Twelve representative strains possessed at least one of the biosynthetic genes coding for polyketide synthase I, II, and nonribosomal peptide synthetase. Four strains had anti-Mycobacterium phlei activities and five strains had activities against methicillin-resistant Staphylococcus aureus. 10 L-scale fermentation of strains Salinispora sp. NHF45, Nocardiopsis sp. NHF48, and Streptomyces sp. NHF86 were carried out for novel and bioactive compounds discovery. Finally, we obtained a novel alpha-pyrone compound from marine Nocardiopsis sp. NHF48, an analogue of paulomenol from marine Streptomyces sp. NHF86 and a new source of rifamycin B, produced by Salinispora sp. NHF45. The present study concluded that marine actinomycetes, which we isolated from South China Sea sediments, will be a suitable source for the development of novel and bioactive compounds.
机译:与陆地菌株相比,海洋放射素对陆地菌株作为天然产物的潜在来源。迄今为止,已经对与华南海洋沉积物相关的培养的放线菌进行了少量的调查。在目前的研究中,通过传统的文化依赖性方法在全疗法后从南海沉积物中回收了28个放线菌。 16S rRNA基因序列分析显示,这些菌株与五个家族和七属相关。十二个代表性菌株具有编码聚酮化合酶I,II和非纤维素肽合成酶的生物合成基因中的至少一种。四种菌株具有抗分子杆菌的活性,5个菌株对耐甲氧西林金黄色葡萄球菌进行活性。 10 L级发酵菌株Salinispora sp。 NHF45,Nocardiopsis sp。 NHF48和Streptomyces SP。 NHF86进行了新的和生物活性化合物发现。最后,我们获得了来自海洋Nocardiopsis SP的新型α-吡喃酮化合物。 NHF48,来自Marine Strepomyces SP的保留酚的类似物。 NHF86和利福霉素B的新来源,由Salinispora Sp产生。 NHF45。本研究得出结论,我们从南海沉积物中孤立的海洋放线菌将是开发新型和生物活性化合物的合适来源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号